4 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Sous presse. Epreuves corrigées par l'auteur. Disponible en ligne depuis le lundi 20 janvier 2020
Doi : 10.1016/j.jaad.2019.10.055
accepted : 22 October 2019
Standardizing serial photography for assessing and monitoring vitiligo: A core set of international recommendations for essential clinical and technical specifications

Nanja van Geel, MD, PhD a, , Iltefat Hamzavi, MD b, Indermeet Kohli, PhD b, Albert Wolkerstorfer, MD, PhD c, Henry W. Lim, MD b, Jung Min Bae, MD, PhD d, Harvey Lui, MD, FRCPC e, f, John E. Harris, MD, PhD g, Amit G. Pandya, MD h, Steven Thng Tien Guan, MBBS, MRCP i, Marwa Abdallah, MD j, Samia Esmat, MD k, Julien Seneschal, MD, PhD l, Reinhart Speeckaert, MD, PhD a, Lynda Grine, MSc, PhD a, Hee Young Kang, MD, PhD m, Noufal Raboobee, MD n, Leihong Flora Xiang, MD, PhD o, Marcel Bekkenk, MD, PhD c, Mauro Picardo, MD p, Alain Taieb, MD, PhD l
a Department of Dermatology, Ghent University Hospital, Ghent, Belgium 
b Department of Dermatology, Henry Ford Hospital, Detroit, Michigan 
c Department of dermatology, institute for pigment disorders and Infection & Immunity Institute Amsterdam UMC, Amsterdam, The Netherlands 
d Department of Dermatology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea 
e Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada 
f Photomedicine Institute, Vancouver Coastal Health Research Institute, Vancouver, British Columbia, Canada 
g Department of Dermatology, The University of Massachusetts Medical School, Worcester, Massachusetts 
h Department of Dermatology, The University of Texas Southwestern Medical Center, Dallas, Texas 
i Skin Research Institute of Singapore, ASTAR, Singapore 
j Dermatology, Andrology, and Venereology Department, Ain Shams University, Cairo, Egypt 
k Department of Dermatology, Faculty Of Medicine Cairo University, Cairo, Egypt 
l INSERM U 1035, University of Bordeaux; Department of Dermatology, Bordeaux University Hospitals, Bordeaux, France 
m Department of Dermatology, Ajou University School of Medicine, Suwon, Korea 
n Department of Dermatology, Westville Hospital, Westville, South Africa 
o Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China 
p San Gallicano Dermatologic Institute, Rome, Italy 

Reprint requests: Nanja van Geel, MD, PhD, Department of Dermatology, Ghent University Hospital, Corneel Heymanslaan 10, 9000 Ghent, Belgium.Department of DermatologyGhent University HospitalCorneel Heymanslaan 10Ghent9000Belgium

Clinical photography is an important component of the initial assessment and follow-up of patients with vitiligo in clinical practice and research settings. Standardization of this photographic process is essential to achieve useful, high-quality, and comparable photographs over time.


The aim is to develop an international consensus for a core set of recommendations for standardized vitiligo clinical photography.


Based an international meeting of vitiligo experts, a standard operating procedure was developed for vitiligo photography in daily practice and research settings. This protocol was subsequently reviewed by 20 vitiligo experts until agreement was reached.


The resulting protocol includes a set of 10 and 15 photographs for clinical practice and research purposes, respectively. The photographic series are based on anatomic units included in the Vitiligo Extent Score. Furthermore, graphic representations of standardized positioning and suggestions for guidelines to standardize the process (background color, lighting, position marking, scales, materials, instruments) for both color and ultraviolet photographs are described.


This consensus-based protocol for vitiligo photography will harmonize imaging for both clinical practice, translational research, and clinical trials. It can improve outcome assessment, foster multicenter collaboration, and promote better communication with patients regarding outcomes of treatment.

The full text of this article is available in PDF format.

Key words : assessment, consensus, imaging, outcome, photography, research, standardized, vitiligo

Abbreviations used : UV, VES

 Funding sources: The research activities of Dr van Geel are supported by the Scientific Research Foundation–Flanders (Fonds Wetenschappelijk Onderzoek [FWO] senior clinical investigator: 1831512N) and Leo Foundation grant (Leo Foundation project reference number LF16092). Supporting sources of organizing the meetings: Vitiligo International Patient Organizations Conference (VIPOC), European Society for Pigment Cell and Melanoma Research (ESPCR) and Associazione Ricerca e Informazione sulla Vitiligine (ARIV) for the Paris meeting, Global Vitiligo Foundation (GVF) for the Detroit meeting.
 Disclosure: Dr van Geel is a consultant and/or investigator for Pfizer, Laboratoire Génévrier, and Incyte. Dr Hamzavi is an investigator for Estee Lauder, Ferndale, Unigen, Johnson and Johnson, Bayer, Allergan, and Incyte and is a consultant for Pfizer, Johnson and Johnson, and Bayer. Dr Kohli is an investigator for Ferndale, Estee Lauder, Unigen, Johnson and Johnson, Allergan, and Bayer and is a consultant for Pfizer, Johnson and Johnson, and Bayer. Dr Lim is a coinvestigator for Incyte. Dr Lui is an investigator/consultant for Pfizer, Johnson & Johnson, Novartis, LEO Pharma, and Sanofi-Genzyme. Dr Harris is a consultant and/or investigator for Pfizer, Genzyme/Sanofi, Stiefel/GlaxoSmithKline, Aclaris Therapeutics, Celgene, Incyte, Dermira, Rheos Medicines, Sun Pharmaceuticals, Leo Pharma, Villaris Therapeutics Inc, AbbVie, Janssen, TeVido BioDevices, EMD Serono, 3rd Rock Ventures, The Expert Institute, and BiologicsMD; has equity in TeVido Biodevices, Rheos, and Villaris Therapeutics, and is the scientific founder of Villaris Therapeutics. Dr Pandya is a consultant for Pfizer, is an investigator for Pfizer and Incyte, and serves on the board of directors of Clarify. Dr Raboobee is an advisory board member of Novartis, Janssen, and AbbVie. Drs Wolkerstorfer, Bae, Thng, Abdallah, Esmat, Seneschal, Speeckaert, Grine, Kang, Xiang, Bekkenk, Picardo, and Taieb have no conflicts of interest to declare.
 IRB approval status: Reported at the local ethics committee at Ghent University Hospital, Belgium.

© 2019  American Academy of Dermatology, Inc. All Rights Reserved.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline